Sarah A Mazzilli
Overview
Explore the profile of Sarah A Mazzilli including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
571
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mazzilli S, Rahal Z, Rouhani M, Janes S, Kadara H, Dubinett S, et al.
Nat Rev Cancer
. 2025 Feb;
PMID: 39994467
Over the past decade, substantial progress has been made in the development of targeted and immune-based therapies for patients with advanced non-small-cell lung cancer. To further improve outcomes for patients...
2.
Arroyo-Ataz G, Yague A, Breda J, Mazzilli S, Jones D
bioRxiv
. 2024 Aug;
PMID: 39091770
Lymphatic muscle cells (LMCs) are indispensable for lymphatic vessel contraction and their aberrant recruitment or absence is associated with both primary and secondary lymphedema. Despite their critical role in lymphatic...
3.
Ysasi A, Engler A, Bawa P, Wang F, Conrad R, Yeung A, et al.
iScience
. 2024 Jul;
27(7):110169.
PMID: 38993668
Macrophages are critical for maintenance and repair of mucosal tissues. While functionally distinct subtypes of macrophage are known to have important roles in injury response and repair in the lungs,...
4.
Steiner D, Sultan L, Sullivan T, Liu H, Zhang S, LeClerc A, et al.
bioRxiv
. 2024 Jun;
PMID: 38915565
Microscopic vascular invasion (VI) is predictive of recurrence and benefit from lobectomy in stage I lung adenocarcinoma (LUAD) but is difficult to assess in resection specimens and cannot be accurately...
5.
Gindra R, Zheng Y, Green E, Reid M, Mazzilli S, Merrick D, et al.
Am J Pathol
. 2024 Apr;
194(7):1285-1293.
PMID: 38588853
Bronchial premalignant lesions (PMLs) precede the development of invasive lung squamous cell carcinoma (LUSC), posing a significant challenge in distinguishing those likely to advance to LUSC from those that might...
6.
Cai L, Gao Y, DeBerardinis R, Acquaah-Mensah G, Aidinis V, Beane J, et al.
bioRxiv
. 2024 Mar;
PMID: 38464291
Lung cancer, the leading cause of cancer mortality, exhibits diverse histological subtypes and genetic complexities. Numerous preclinical mouse models have been developed to study lung cancer, but data from these...
7.
Bruhm D, Mathios D, Foda Z, Annapragada A, Medina J, Adleff V, et al.
Nat Genet
. 2023 Jul;
55(8):1301-1310.
PMID: 37500728
Somatic mutations are a hallmark of tumorigenesis and may be useful for non-invasive diagnosis of cancer. We analyzed whole-genome sequencing data from 2,511 individuals in the Pan-Cancer Analysis of Whole...
8.
Yanagawa J, Tran L, Salehi-Rad R, Lim R, Dumitras C, Fung E, et al.
Cancer Res
. 2023 Jul;
83(19):3305-3319.
PMID: 37477508
Significance: Analysis of a spectrum of subsolid pulmonary nodules by single-cell RNA sequencing provides insights into the immune regulation and cell-cell interactions in the tumor microenvironment during early lung tumor...
9.
Xu K, Shi X, Husted C, Hong R, Wang Y, Ning B, et al.
Sci Rep
. 2022 Oct;
12(1):18168.
PMID: 36307504
SARS-CoV-2 infection and disease severity are influenced by viral entry (VE) gene expression patterns in the airway epithelium. The similarities and differences of VE gene expression (ACE2, TMPRSS2, and CTSL)...
10.
Maoz A, Merenstein C, Koga Y, Potter A, Gower A, Liu G, et al.
J Immunother Cancer
. 2021 Sep;
9(9).
PMID: 34580161
Objective: The immune response to invasive carcinoma has been the focus of published work, but little is known about the adaptive immune response to bronchial premalignant lesions (PMLs), precursors of...